General Anesthetics - Global and China Top Players Market Share and Ranking 2024
This report studies and analyses global General Anesthetics status and future trends, helps the client to determine the General Anesthetics market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for General Anesthetics, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global General Anesthetics market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global General Anesthetics sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China General Anesthetics sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global General Anesthetics key consuming regions, consumption quantity, consumption value and demand structure
(5) Global General Anesthetics key producing regions, capacity, production, and year over year growth
(6) General Anesthetics industry chains, upstream, midstream and downstream
According to latest study, the global market for General Anesthetics should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China General Anesthetics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States General Anesthetics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Ambulatory Surgery Center grew percent.
Market segment by players, this report covers
Abbott Laboratories
AbbVie
Aspen Pharmacare
AstraZeneca
B. Braun Melsungen AG
Baxter International
Boehringer Ingelheim
Eisai
Endo International
Fresenius Kabi AG
GlaxoSmithKline
Hikma Pharmaceuticals
Jiangsu Hengrui Pharmaceutical Co., Ltd.
Johnson & Johnson
Lannett
Merck
Market segment by Type, covers
Inhalation Anesthestic
Intravenous Anesthestic
Market segment by Application, can be divided into
Hospital
Ambulatory Surgery Center
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe General Anesthetics product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global General Anesthetics market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China General Anesthetics market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of General Anesthetics, percent & CAGR, 2018-2029
Chapter 5: General Anesthetics industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 General Anesthetics Definition
1.2 Global General Anesthetics Market Size and Forecast
1.2.1 By Consumption Value, Global General Anesthetics Market Size，2018-2029
1.2.2 By Sales Quantity, Global General Anesthetics Market Size，2018-2029
1.2.3 Global General Anesthetics Average Selling Price (ASP)，2018-2029
1.3 China General Anesthetics Market Size and Forecast
1.3.1 By Consumption Value, China General Anesthetics Market Size，2018-2029
1.3.2 By Sales Quantity, China General Anesthetics Market Size，2018-2029
1.3.3 China General Anesthetics Average Selling Price (ASP)， 2018-2029
1.4 Share of China General Anesthetics Market with Respect to the Global Market
1.4.1 By Consumption Value, China General Anesthetics Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China General Anesthetics Market Share in Global, 2018-2029
1.4.3 General Anesthetics Market Size: China VS Global, 2018-2029
1.5 General Anesthetics Market Dynamics
1.5.1 General Anesthetics Market Drivers
1.5.2 General Anesthetics Market Restraints
1.5.3 General Anesthetics Industry Trends
1.5.4 General Anesthetics Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of General Anesthetics, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of General Anesthetics, Global Market Share by Company, 2018-2023
2.3 General Anesthetics Average Selling Price (ASP) by Company, 2018-2023
2.4 Global General Anesthetics Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global General Anesthetics Concentration Ratio
2.6 Global General Anesthetics Mergers & Acquisitions, Expansion Plans
2.7 Global General Anesthetics Manufacturers Product Type
2.8 Head Office and General Anesthetics Production Site of Key Manufacturer
2.9 General Anesthetics Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of General Anesthetics, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of General Anesthetics, China Market Share by Company, 2018-2023
3.3 China General Anesthetics Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global General Anesthetics Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global General Anesthetics Capacity by Region
4.3 Global General Anesthetics Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global General Anesthetics Production by Region, 2018-2029
4.5 Global General Anesthetics Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 General Anesthetics Industry Chain
5.2 General Anesthetics Upstream Analysis
5.2.1 General Anesthetics Core Raw Materials
5.2.2 Main Manufacturers of General Anesthetics Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 General Anesthetics Production Mode
5.6 General Anesthetics Procurement Model
5.7 General Anesthetics Industry Sales Model and Sales Channels
5.7.1 General Anesthetics Sales Model
5.7.2 General Anesthetics Typical Distributors
6 Sights by Type
6.1 General Anesthetics Classification
6.1.1 Inhalation Anesthestic
6.1.2 Intravenous Anesthestic
6.2 By Type, Global General Anesthetics Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global General Anesthetics Consumption Value, 2018-2029
6.4 By Type, Global General Anesthetics Sales Quantity, 2018-2029
6.5 By Type, Global General Anesthetics Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 General Anesthetics Segment by Application
7.1.1 Hospital
7.1.2 Ambulatory Surgery Center
7.1.3 Others
7.2 By Application, Global General Anesthetics Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global General Anesthetics Consumption Value, 2018-2029
7.4 By Application, Global General Anesthetics Sales Quantity, 2018-2029
7.5 By Application, Global General Anesthetics Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global General Anesthetics Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global General Anesthetics Consumption Value, 2018-2029
8.3 By Region, Global General Anesthetics Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America General Anesthetics & Forecasts, 2018-2029
8.4.2 By Country, North America General Anesthetics Market Size Market Share
8.5 Europe
8.5.1 Europe General Anesthetics Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe General Anesthetics Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific General Anesthetics Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific General Anesthetics Market Size Market Share
8.7 South America
8.7.1 South America General Anesthetics Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America General Anesthetics Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global General Anesthetics Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global General Anesthetics Consumption Value, 2018-2029
9.3 By Country, Global General Anesthetics Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. General Anesthetics Market Size, 2018-2029
9.4.2 By Type, U.S. General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe General Anesthetics Market Size, 2018-2029
9.5.2 By Type, Europe General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China General Anesthetics Market Size, 2018-2029
9.6.2 By Type, China General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan General Anesthetics Market Size, 2018-2029
9.7.2 By Type, Japan General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea General Anesthetics Market Size, 2018-2029
9.8.2 By Type, South Korea General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia General Anesthetics Market Size, 2018-2029
9.9.2 By Type, Southeast Asia General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India General Anesthetics Market Size, 2018-2029
9.10.2 By Type, India General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa General Anesthetics Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa General Anesthetics Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa General Anesthetics Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position
10.1.2 Abbott Laboratories General Anesthetics Models, Specifications, and Application
10.1.3 Abbott Laboratories General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Abbott Laboratories Company Profile and Main Business
10.1.5 Abbott Laboratories Recent Developments
10.2 AbbVie
10.2.1 AbbVie Company Information, Head Office, Market Area, and Industry Position
10.2.2 AbbVie General Anesthetics Models, Specifications, and Application
10.2.3 AbbVie General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 AbbVie Company Profile and Main Business
10.2.5 AbbVie Recent Developments
10.3 Aspen Pharmacare
10.3.1 Aspen Pharmacare Company Information, Head Office, Market Area, and Industry Position
10.3.2 Aspen Pharmacare General Anesthetics Models, Specifications, and Application
10.3.3 Aspen Pharmacare General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Aspen Pharmacare Company Profile and Main Business
10.3.5 Aspen Pharmacare Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.4.2 AstraZeneca General Anesthetics Models, Specifications, and Application
10.4.3 AstraZeneca General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AstraZeneca Company Profile and Main Business
10.4.5 AstraZeneca Recent Developments
10.5 B. Braun Melsungen AG
10.5.1 B. Braun Melsungen AG Company Information, Head Office, Market Area, and Industry Position
10.5.2 B. Braun Melsungen AG General Anesthetics Models, Specifications, and Application
10.5.3 B. Braun Melsungen AG General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 B. Braun Melsungen AG Company Profile and Main Business
10.5.5 B. Braun Melsungen AG Recent Developments
10.6 Baxter International
10.6.1 Baxter International Company Information, Head Office, Market Area, and Industry Position
10.6.2 Baxter International General Anesthetics Models, Specifications, and Application
10.6.3 Baxter International General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Baxter International Company Profile and Main Business
10.6.5 Baxter International Recent Developments
10.7 Boehringer Ingelheim
10.7.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position
10.7.2 Boehringer Ingelheim General Anesthetics Models, Specifications, and Application
10.7.3 Boehringer Ingelheim General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Boehringer Ingelheim Company Profile and Main Business
10.7.5 Boehringer Ingelheim Recent Developments
10.8 Eisai
10.8.1 Eisai Company Information, Head Office, Market Area, and Industry Position
10.8.2 Eisai General Anesthetics Models, Specifications, and Application
10.8.3 Eisai General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Eisai Company Profile and Main Business
10.8.5 Eisai Recent Developments
10.9 Endo International
10.9.1 Endo International Company Information, Head Office, Market Area, and Industry Position
10.9.2 Endo International General Anesthetics Models, Specifications, and Application
10.9.3 Endo International General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Endo International Company Profile and Main Business
10.9.5 Endo International Recent Developments
10.10 Fresenius Kabi AG
10.10.1 Fresenius Kabi AG Company Information, Head Office, Market Area, and Industry Position
10.10.2 Fresenius Kabi AG General Anesthetics Models, Specifications, and Application
10.10.3 Fresenius Kabi AG General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Fresenius Kabi AG Company Profile and Main Business
10.10.5 Fresenius Kabi AG Recent Developments
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Company Information, Head Office, Market Area, and Industry Position
10.11.2 GlaxoSmithKline General Anesthetics Models, Specifications, and Application
10.11.3 GlaxoSmithKline General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 GlaxoSmithKline Company Profile and Main Business
10.11.5 GlaxoSmithKline Recent Developments
10.12 Hikma Pharmaceuticals
10.12.1 Hikma Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.12.2 Hikma Pharmaceuticals General Anesthetics Models, Specifications, and Application
10.12.3 Hikma Pharmaceuticals General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Hikma Pharmaceuticals Company Profile and Main Business
10.12.5 Hikma Pharmaceuticals Recent Developments
10.13 Jiangsu Hengrui Pharmaceutical Co., Ltd.
10.13.1 Jiangsu Hengrui Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position
10.13.2 Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Models, Specifications, and Application
10.13.3 Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Jiangsu Hengrui Pharmaceutical Co., Ltd. Company Profile and Main Business
10.13.5 Jiangsu Hengrui Pharmaceutical Co., Ltd. Recent Developments
10.14 Johnson & Johnson
10.14.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.14.2 Johnson & Johnson General Anesthetics Models, Specifications, and Application
10.14.3 Johnson & Johnson General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Johnson & Johnson Company Profile and Main Business
10.14.5 Johnson & Johnson Recent Developments
10.15 Lannett
10.15.1 Lannett Company Information, Head Office, Market Area, and Industry Position
10.15.2 Lannett General Anesthetics Models, Specifications, and Application
10.15.3 Lannett General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Lannett Company Profile and Main Business
10.15.5 Lannett Recent Developments
10.16 Merck
10.16.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.16.2 Merck General Anesthetics Models, Specifications, and Application
10.16.3 Merck General Anesthetics Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Merck Company Profile and Main Business
10.16.5 Merck Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. General Anesthetics Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million_x000D_
Table 2. General Anesthetics Market Restraints_x000D_
Table 3. General Anesthetics Market Trends_x000D_
Table 4. General Anesthetics Industry Policy_x000D_
Table 5. Global General Anesthetics Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022_x000D_
Table 6. Global General Anesthetics Revenue Share by Company, 2018-2023, Ranked by Data of 2022_x000D_
Table 7. Global General Anesthetics Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022_x000D_
Table 8. Global General Anesthetics Sales Quantity by Company, 2018-2023, Ranked by Data of 2022_x000D_
Table 9. Global General Anesthetics Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)_x000D_
Table 10. Global General Anesthetics Manufacturers Market Concentration Ratio (CR3 and HHI)_x000D_
Table 11. Global General Anesthetics Mergers & Acquisitions, Expansion Plans_x000D_
Table 12. Global General Anesthetics Manufacturers Product Type_x000D_
Table 13. Head Office and General Anesthetics Production Site of Key Manufacturer_x000D_
Table 14. General Anesthetics Capacity of Major Manufacturers and Future Plan_x000D_
Table 15. China General Anesthetics Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022_x000D_
Table 16. China General Anesthetics Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022_x000D_
Table 17. China General Anesthetics Sales Quantity by Company, 2018-2023, Ranked by Data of 2022_x000D_
Table 18. Global General Anesthetics Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)_x000D_
Table 19. Global General Anesthetics Production by Region, 2018-2023, (K Units)_x000D_
Table 20. Global General Anesthetics Production Forecast by Region, 2024-2029, (K Units)_x000D_
Table 21. Global Key Players of General Anesthetics Upstream (Raw Materials)_x000D_
Table 22. Global General Anesthetics Typical Customers_x000D_
Table 23. General Anesthetics Typical Distributors_x000D_
Table 24. By Type, Global General Anesthetics Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_
Table 25. By Application, Global General Anesthetics Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_
Table 26. By Region, Global General Anesthetics Consumption Value, 2018 VS 2022 VS 2029, US$ Million_x000D_
Table 27. By Region, Global General Anesthetics Consumption Value, 2018-2029, US$ Million_x000D_
Table 28. By Region, Global General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Table 29. By Country, Global General Anesthetics Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million_x000D_
Table 30. By Country, Global General Anesthetics Consumption Value, 2018-2029, US$ Million_x000D_
Table 31. By Country, Global General Anesthetics Consumption Value Market Share, 2018-2029_x000D_
Table 32. By Country, Global General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Table 33. By Country, Global General Anesthetics Sales Quantity Market Share, 2018-2029_x000D_
Table 34. Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 35. Abbott Laboratories General Anesthetics Models, Specifications, and Application_x000D_
Table 36. Abbott Laboratories General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 37. Abbott Laboratories Company Profile and Main Business_x000D_
Table 38. Abbott Laboratories Recent Developments_x000D_
Table 39. AbbVie Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 40. AbbVie General Anesthetics Models, Specifications, and Application_x000D_
Table 41. AbbVie General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 42. AbbVie Company Profile and Main Business_x000D_
Table 43. AbbVie Recent Developments_x000D_
Table 44. Aspen Pharmacare Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 45. Aspen Pharmacare General Anesthetics Models, Specifications, and Application_x000D_
Table 46. Aspen Pharmacare General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 47. Aspen Pharmacare Company Profile and Main Business_x000D_
Table 48. Aspen Pharmacare Recent Developments_x000D_
Table 49. AstraZeneca Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 50. AstraZeneca General Anesthetics Models, Specifications, and Application_x000D_
Table 51. AstraZeneca General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 52. AstraZeneca Company Profile and Main Business_x000D_
Table 53. AstraZeneca Recent Developments_x000D_
Table 54. B. Braun Melsungen AG Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 55. B. Braun Melsungen AG General Anesthetics Models, Specifications, and Application_x000D_
Table 56. B. Braun Melsungen AG General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 57. B. Braun Melsungen AG Company Profile and Main Business_x000D_
Table 58. B. Braun Melsungen AG Recent Developments_x000D_
Table 59. Baxter International Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 60. Baxter International General Anesthetics Models, Specifications, and Application_x000D_
Table 61. Baxter International General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 62. Baxter International Company Profile and Main Business_x000D_
Table 63. Baxter International Recent Developments_x000D_
Table 64. Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 65. Boehringer Ingelheim General Anesthetics Models, Specifications, and Application_x000D_
Table 66. Boehringer Ingelheim General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 67. Boehringer Ingelheim Company Profile and Main Business_x000D_
Table 68. Boehringer Ingelheim Recent Developments_x000D_
Table 69. Eisai Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 70. Eisai General Anesthetics Models, Specifications, and Application_x000D_
Table 71. Eisai General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 72. Eisai Company Profile and Main Business_x000D_
Table 73. Eisai Recent Developments_x000D_
Table 74. Endo International Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 75. Endo International General Anesthetics Models, Specifications, and Application_x000D_
Table 76. Endo International General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 77. Endo International Company Profile and Main Business_x000D_
Table 78. Endo International Recent Developments_x000D_
Table 79. Fresenius Kabi AG Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 80. Fresenius Kabi AG General Anesthetics Models, Specifications, and Application_x000D_
Table 81. Fresenius Kabi AG General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 82. Fresenius Kabi AG Company Profile and Main Business_x000D_
Table 83. Fresenius Kabi AG Recent Developments_x000D_
Table 84. GlaxoSmithKline Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 85. GlaxoSmithKline General Anesthetics Models, Specifications, and Application_x000D_
Table 86. GlaxoSmithKline General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 87. GlaxoSmithKline Company Profile and Main Business_x000D_
Table 88. GlaxoSmithKline Recent Developments_x000D_
Table 89. Hikma Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 90. Hikma Pharmaceuticals General Anesthetics Models, Specifications, and Application_x000D_
Table 91. Hikma Pharmaceuticals General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 92. Hikma Pharmaceuticals Company Profile and Main Business_x000D_
Table 93. Hikma Pharmaceuticals Recent Developments_x000D_
Table 94. Jiangsu Hengrui Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 95. Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Models, Specifications, and Application_x000D_
Table 96. Jiangsu Hengrui Pharmaceutical Co., Ltd. General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 97. Jiangsu Hengrui Pharmaceutical Co., Ltd. Company Profile and Main Business_x000D_
Table 98. Jiangsu Hengrui Pharmaceutical Co., Ltd. Recent Developments_x000D_
Table 99. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 100. Johnson & Johnson General Anesthetics Models, Specifications, and Application_x000D_
Table 101. Johnson & Johnson General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 102. Johnson & Johnson Company Profile and Main Business_x000D_
Table 103. Johnson & Johnson Recent Developments_x000D_
Table 104. Lannett Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 105. Lannett General Anesthetics Models, Specifications, and Application_x000D_
Table 106. Lannett General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 107. Lannett Company Profile and Main Business_x000D_
Table 108. Lannett Recent Developments_x000D_
Table 109. Merck Company Information, Head Office, Market Area, and Industry Position_x000D_
Table 110. Merck General Anesthetics Models, Specifications, and Application_x000D_
Table 111. Merck General Anesthetics Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023_x000D_
Table 112. Merck Company Profile and Main Business_x000D_
Table 113. Merck Recent Developments_x000D_
List of Figures_x000D_
Figure 1. General Anesthetics Picture_x000D_
Figure 2. Global General Anesthetics Consumption Value, (US$ million) & (2018-2029)_x000D_
Figure 3. Global General Anesthetics Sales Quantity, (K Units) & (2018-2029)_x000D_
Figure 4. Global General Anesthetics Average Selling Price (ASP), (2018-2029) & (US$/Unit)_x000D_
Figure 5. China General Anesthetics Consumption Value, (US$ million) & (2018-2029)_x000D_
Figure 6. China General Anesthetics Sales Quantity (K Units) & (2018-2029)_x000D_
Figure 7. China General Anesthetics Average Selling Price (ASP), (US$/Unit) & (2018-2029)_x000D_
Figure 8. By Consumption Value, China General Anesthetics Market Share of Global, 2018-2029_x000D_
Figure 9. By Sales Quantity, China General Anesthetics Market Share of Global, 2018-2029_x000D_
Figure 10. Global General Anesthetics Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022_x000D_
Figure 11. China General Anesthetics Key Participants, Market Share, 2022_x000D_
Figure 12. Global General Anesthetics Capacity, Production and Capacity Utilization, 2018-2029_x000D_
Figure 13. Global General Anesthetics Capacity Market Share by Region, 2022 VS 2029_x000D_
Figure 14. Global General Anesthetics Production Market Share & Forecast by Region, 2018-2029_x000D_
Figure 15. General Anesthetics Industry Chain_x000D_
Figure 16. General Anesthetics Procurement Model_x000D_
Figure 17. General Anesthetics Sales Model_x000D_
Figure 18. General Anesthetics Sales Channels, Direct Sales, and Distribution_x000D_
Figure 19. Inhalation Anesthestic_x000D_
Figure 20. Intravenous Anesthestic_x000D_
Figure 21. By Type, Global General Anesthetics Consumption Value, 2018-2029, US$ Million_x000D_
Figure 22. By Type, Global General Anesthetics Consumption Value Market Share, 2018-2029_x000D_
Figure 23. By Type, Global General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Figure 24. By Type, Global General Anesthetics Sales Quantity Market Share, 2018-2029_x000D_
Figure 25. By Type, Global General Anesthetics Average Selling Price (ASP), 2018-2029, (US$/Unit)_x000D_
Figure 26. Hospital_x000D_
Figure 27. Ambulatory Surgery Center_x000D_
Figure 28. Others_x000D_
Figure 29. By Application, Global General Anesthetics Consumption Value, 2018-2029, US$ Million_x000D_
Figure 30. By Application, Global General Anesthetics Consumption Value Market Share, 2018-2029_x000D_
Figure 31. By Application, Global General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Figure 32. By Application, Global General Anesthetics Sales Quantity Market Share, 2018-2029_x000D_
Figure 33. By Application, Global General Anesthetics Average Selling Price (ASP), 2018-2029, (US$/Unit)_x000D_
Figure 34. By Region, Global General Anesthetics Consumption Value Market Share, 2018-2029_x000D_
Figure 35. By Region, Global General Anesthetics Sales Quantity Market Share, 2018-2029_x000D_
Figure 36. North America General Anesthetics Consumption Value & Forecasts, 2018-2029, US$ Million_x000D_
Figure 37. By Country, North America General Anesthetics Consumption Value Market Share, 2022_x000D_
Figure 38. Europe General Anesthetics Consumption Value & Forecasts, 2018-2029, US$ Million_x000D_
Figure 39. By Country, Europe General Anesthetics Consumption Value Market Share, 2022_x000D_
Figure 40. Asia Pacific General Anesthetics Consumption Value & Forecasts, 2018-2029, US$ Million_x000D_
Figure 41. By Country/Region, Asia Pacific General Anesthetics Consumption Value Market Share, 2022_x000D_
Figure 42. South America General Anesthetics Consumption Value & Forecasts, 2018-2029, US$ Million_x000D_
Figure 43. By Country, South America General Anesthetics Consumption Value Market Share, 2022_x000D_
Figure 44. Middle East & Africa General Anesthetics Consumption Value & Forecasts, 2018-2029, US$ Million_x000D_
Figure 45. U.S. General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Figure 46. By Type, U.S. General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 47. By Application, U.S. General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 48. Europe General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Figure 49. By Type, Europe General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 50. By Application, Europe General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 51. China General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Figure 52. By Type, China General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 53. By Application, China General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 54. Japan General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Figure 55. By Type, Japan General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 56. By Application, Japan General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 57. South Korea General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Figure 58. By Type, South Korea General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 59. By Application, South Korea General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 60. Southeast Asia General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Figure 61. By Type, Southeast Asia General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 62. By Application, Southeast Asia General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 63. India General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Figure 64. By Type, India General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 65. By Application, India General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 66. Middle East & Africa General Anesthetics Sales Quantity, 2018-2029, (K Units)_x000D_
Figure 67. By Type, Middle East & Africa General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 68. By Application, Middle East & Africa General Anesthetics Sales Quantity Market Share, 2022 VS 2029_x000D_
Figure 69. Research Methodology_x000D_
Figure 70. Breakdown of Primary Interviews_x000D_
Figure 71. Bottom-up and Top-down Approaches_x000D_
Figure 72. Top-down Approaches_x000D_
_x000D_
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|